According to the most recent report by Emergen Research, the global anastomosis devices market is predicted to grow at a revenue CAGR of 5.6% over the forecast period, reaching USD 3.58 billion in 2021. An increase in surgical operations and an increase in gastrointestinal and cardiovascular disorders are the two trends that are most important in driving the market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs), which account for 17.9 million fatalities per year, are the leading cause of death worldwide. Increased research and development are required due to the rise in disorders affecting the heart and digestive system. The market will grow and cutting-edge technologies will be incorporated in anastomosis devices due to the demand for better patient outcomes.
The market for anastomosis devices is expanding due to the development of technologically improved products and advantageous reimbursement scenarios in cardiac surgeries such as Coronary Bypass Graft Surgery (CABG), open-heart valve replacement, and angioplasty in developed nations. For instance, Medicare Part B covers complete Cardiac Rehabilitation (CR) programmes, coronary artery bypass graft surgery, coronary angioplasty, valve repair & replacement, and other medical procedures.
Please Check Out Our Free Sample Reports and Make a More Informed Decision: @ https://www.emergenresearch.com/request-sample/1414
Several Important Report Highlights
In 2021, the disposable sector represented the greatest revenue share. The segment’s revenue is increasing as a result of greater market penetration and the accessibility of a variety of disposable anastomotic products. The majority of the important players are engaged in the production of throwaway goods. These products lessen the chance of cross-infection, surgical site contamination, and other healthcare-related concerns.
In 2021, the hospital segment’s revenue share was the highest. The increasing patient load brought on by the prevalence of gastrointestinal, cardiovascular, and a number of other ailments is a significant factor fueling this segment’s revenue rise. Due to improved hospital healthcare facilities, financing options and easy access to therapy are also contributing to the segment’s revenue growth.
In terms of revenue share, North America’s market dominated in 2021. The substantial number of market businesses investing in anastomosis devices is a crucial element influencing market revenue growth in this area. For instance, Johnson & Johnson Private Limited, Artivion, Inc., and Medtronic are a few of the most well-known startups in this field. It is anticipated that as more biomedical enterprises invest in the development of surgical equipment based on anastomoses, the number of product launches will rise dramatically.
Medtronic, Artivion, Inc., MAQUET Holding B.V. & Co. KG., Dextera Surgical Inc., Vitalitec International Inc., Synovis Micro Firms Alliance, Inc., Ethicon US, LLC, and Peters Surgical are a few of the significant companies in the global market study.
Enquire for customization in Report @: https://www.emergenresearch.com/request-for-customization/1414
Growing Points
The market for anastomosis devices is frequently driven by an increase in the number of cardiovascular tasks done as well as a rise in the frequency of chronic illnesses like heart disease and digestive problems. One of the major causes of mortality worldwide is cardiovascular disease. The World Health Organization estimates that 17.9 million people died in 2019 from cardiovascular diseases, accounting for around 32% of all fatalities overall. Additionally, 85% of these fatalities were caused by heart attacks and strokes. Later on, this will increase interest in anastomosis devices. In order to improve healing outcomes, more creative work practises on anastomosis device progression are being coordinated.
The market for anastomosis devices is being driven ahead by the advancement of exactly further developed products and successful reimbursement conditions in cardiovascular surgeries like Coronary Bypass Graft Surgery, open-heart valve replacement, and angioplasty in developed countries. For instance, government clinical protection Part B includes valve repair and replacement, coronary angioplasty, and other comprehensive Cardiac Rehabilitation programmes.
Forecasting The Impact Of COVID-19 On The Market For Anastomosis Devices
The COVID-19 epidemic had a negative effect on market predictions because there was a severe lack of the medical equipment required to carry out complicated surgery. The demand-supply imbalance for essential tools like anastomosis devices was widening, which slowed the development of the healthcare industry. The demand for anastomosis devices, however, is anticipated to expand significantly as the situation gradually improves because the virus was also to blame for an increase in cardiovascular cases globally.
To Visit Full Report & Table of Contents Anastomosis Devices Market: https://www.emergenresearch.com/industry-report/anastomosis-devices-market
Emergen Research has segmented the global anastomosis devices market on the basis of medical applications, product type, end-use, and region:
- Medical Applications Outlook (Revenue, USD Billion; 2019-2030)
- Cardiovascular Surgery
- Gastrointestinal Surgery
- Others
- Product Type Outlook (Revenue, USD Billion; 2019-2030)
- Disposable
- Reusable
- Others
- End-use Outlook (Revenue, USD Billion; 2019-2030)
- Hospitals
- Clinics
- Ambulatory Care Centers
- Others
- Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- France
- K.
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
See a related report from Emergen Research
Hemodynamic Monitoring Devices Market
Negative Pressure Wound Therapy Market
Near Infrared Spectroscopy Market
Robotics Surgical Simulation Systems Market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Trending Titles: Negative Pressure Wound Therapy Market | Biostimulants Market
Latest Report: Electrophysiology Market | Dermatology Devices Market